Sernova Biotherapeutics Strengthens Balance Sheet with $7.1 Million in Financings Plus Net Retirement of a Cumulative $17 Million of Debt Subject to Shareholder Approval
SVASEOVF|Bullish|4 Mar 2026 · about 5 hours ago
Read More →Want to know today's top companies with the most bullish news? Subscribe to our FREE newsletter
1 article · filtered by SVA